View in EDS HTML Full Text PDF Full Text

An Open‐Label, Single‐Arm, Phase II Trial of Sintilimab Plus Anlotinib for Metastatic Non‐Small Cell Lung Cancer After First‐Line PD‐(L)1 Inhibitor.

Saved in:
Bibliographic Details
Title: An Open‐Label, Single‐Arm, Phase II Trial of Sintilimab Plus Anlotinib for Metastatic Non‐Small Cell Lung Cancer After First‐Line PD‐(L)1 Inhibitor.
Authors: Shi, Xun1 (AUTHOR), Lin, Chen1 (AUTHOR), Lou, Lishu1 (AUTHOR), He, Qiong1 (AUTHOR), Lou, Guangyuan1 (AUTHOR), Hong, Wei1 (AUTHOR), Shao, Lan1 (AUTHOR), Zhao, Jun1 (AUTHOR), Gu, Cuiping1 (AUTHOR), Yu, Xinmin1 (AUTHOR) yuxm@zjcc.org.cn, Jin, Ying1 (AUTHOR) jinying@zjcc.org.cn
Source: Cancer Medicine. Sep2025, Vol. 14 Issue 17, p1-9. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 187891403
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: An Open‐Label, Single‐Arm, Phase II Trial of Sintilimab Plus Anlotinib for Metastatic Non‐Small Cell Lung Cancer After First‐Line PD‐(L)1 Inhibitor.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Shi%2C+Xun%22">Shi, Xun</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lin%2C+Chen%22">Lin, Chen</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lou%2C+Lishu%22">Lou, Lishu</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22He%2C+Qiong%22">He, Qiong</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lou%2C+Guangyuan%22">Lou, Guangyuan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hong%2C+Wei%22">Hong, Wei</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shao%2C+Lan%22">Shao, Lan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhao%2C+Jun%22">Zhao, Jun</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gu%2C+Cuiping%22">Gu, Cuiping</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yu%2C+Xinmin%22">Yu, Xinmin</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> yuxm@zjcc.org.cn</i><br /><searchLink fieldCode="AR" term="%22Jin%2C+Ying%22">Jin, Ying</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> jinying@zjcc.org.cn</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Cancer+Medicine%22">Cancer Medicine</searchLink>. Sep2025, Vol. 14 Issue 17, p1-9. 9p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=187891403
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cam4.71191
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 1
    Titles:
      – TitleFull: An Open‐Label, Single‐Arm, Phase II Trial of Sintilimab Plus Anlotinib for Metastatic Non‐Small Cell Lung Cancer After First‐Line PD‐(L)1 Inhibitor.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shi, Xun
      – PersonEntity:
          Name:
            NameFull: Lin, Chen
      – PersonEntity:
          Name:
            NameFull: Lou, Lishu
      – PersonEntity:
          Name:
            NameFull: He, Qiong
      – PersonEntity:
          Name:
            NameFull: Lou, Guangyuan
      – PersonEntity:
          Name:
            NameFull: Hong, Wei
      – PersonEntity:
          Name:
            NameFull: Shao, Lan
      – PersonEntity:
          Name:
            NameFull: Zhao, Jun
      – PersonEntity:
          Name:
            NameFull: Gu, Cuiping
      – PersonEntity:
          Name:
            NameFull: Yu, Xinmin
      – PersonEntity:
          Name:
            NameFull: Jin, Ying
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: Sep2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 20457634
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 17
          Titles:
            – TitleFull: Cancer Medicine
              Type: main
ResultId 1